Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Oliver Hao
    Oliver Hao
    Co-CEO

    Canada McGill University MBA/Canada CPA

    Mr. Hao previously served as SVP of strategic development and GM at 111 Inc. (NASDAQ: 111) and participated in the company‘s IPO in 2018. Previously, he served as the co-CEO of Sinco Pharm (Hongkong: 6833), VP and GM of the pharmaceutical business in China for Cardinal Health.

    详情介绍

    Name:Oliver Hao

    Position:Co-CEO

    Profile: Canada McGill University MBA/Canada CPA

    Mr. Hao previously served as SVP of strategic development and GM at 111 Inc. (NASDAQ: 111) and participated in the company‘s IPO in 2018. Previously, he served as the co-CEO of Sinco Pharm (Hongkong: 6833), VP and GM of the pharmaceutical business in China for Cardinal Health.

    Before that, Mr. Hao also worked as the finance director at Cardinal Health China and financial controller for Eli Lilly in China and Canada.

    Mr. Hao has developed strong skills in such areas as strategic development, financial management, digital marketing and sales management. 

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.